Iovance Tumbles After Delaying FDA Cancer Drug Application

Cristopher Centers

Iovance Biotherapeutics Inc.  (IOVA) – Get Report shares tumbled Tuesday after the cancer drug developer said it will delay its application to the Food & Drug Administration for an experimental treatment until later next year. Iovance said that while its confident in the data its seeing from trials of lifileucel, a […]

Iovance Biotherapeutics Inc.  (IOVA) – Get Report shares tumbled Tuesday after the cancer drug developer said it will delay its application to the Food & Drug Administration for an experimental treatment until later next year.

Iovance said that while its confident in the data its seeing from trials of lifileucel, a developing drug aimed at patients suffering from metastatic melanoma, a form of skin cancer, it has been unable to agree with the FDA on a timeline for its formal Biologics License Application. 

Next Post

Dave Shepard Sentenced to Life in Prison for Joseph Sonnier’s Murder

ABC News Haley, Abigail, and Rachel Shepard talk to 20/20 about their father. In 2012, pathologist Dr. Joseph Sonnier was found shot and stabbed to death in his Lubbock, Texas, home. It was not a robbery gone wrong — and it actually turned out to be a murder-for-hire case. Dave […]